Showing results (71-80 of 174) with videos related to
Sort By:
Pageof 18
Leukemia & Lymphoma|August 23, 2000
Accumulation of sestamibi in lymphoma cell lines in vitroM Kim, M V Gronda, H A Messner, et al.Magnetic Resonance Imaging|January 1, 1993
Mechanisms that contribute to the in vitro relaxation and signal intensity of water in barium sulfate suspensions used as MRI contrast agentsR W Briggs, T Liebig, J R Ballinger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Formulation of technetium-99m-aerosol colloid with improved delivery efficiency for lung ventilation imagingJ R Ballinger, T W Andrey, I Boxen, et al.Journal of Nuclear Medicine Technology|June 3, 1999
External radioactive reference markers in SPECT imaging of the dopamine systemD C Vines, B D Ivo, J R Ballinger, et al.Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Flux through multicellular layers of a technetium-99m-nitroimidazole for imaging hypoxiaTricia Melo, Jonathan K Tunggal, James R Ballinger, et al.The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1991
The psychiatric symptoms, diagnoses and care needs of 100 mentally handicapped patientsB R Ballinger, C B Ballinger, A H Reid, et al.Bioconjugate Chemistry|September 30, 1999
Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technologyR Dunn-Dufault, A Pollak, J R Thornback, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1975
Use of a standardized psychiatric interview in mentally handicapped patientsB R Ballinger, J Armstrong, A S Presly, et al.Biochemical Pharmacology|October 6, 1997
Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromaticsT Melo, H A Hua, J R Ballinger, et al.Pageof 18